Abstract
Presented at the Great Lakes Pharmacy Residents Conference. West Lafayette, IN: April 2024.
This retrospective, post-implementation study found that 81% of patients with a documented penicillin allergy could be de-labeled, and that the majority could theoretically tolerate a penicillin challenge.
Document Type
Conference Proceeding
Publication Date
4-2024
Recommended Citation
McCarthy, Jennifer PharmD, MS, "Penicillin Allergy De-labeling: Evaluating a Health System’s Implementation of the PEN-FAST Tool within an Infectious Disease Clinic." (2024). Pharmacy Residency. 27.
https://researchrepository.parkviewhealth.org/pharmresidency/27